172 related articles for article (PubMed ID: 37252774)
1. Barriers and Facilitators to Implementing a Digital Adherence Technology for Tuberculosis Treatment Supervision in Uganda: Qualitative Study.
Leddy A; Ggita J; Berger CA; Kityamuwesi A; Sanyu AN; Tinka LK; Crowder R; Turyahabwe S; Katamba A; Cattamanchi A
J Med Internet Res; 2023 May; 25():e38828. PubMed ID: 37252774
[TBL] [Abstract][Full Text] [Related]
2. Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in Uganda.
Kiwanuka N; Kityamuwesi A; Crowder R; Guzman K; Berger CA; Lamunu M; Namale C; Kunihira Tinka L; Nakate AS; Ggita J; Turimumahoro P; Babirye D; Oyuku D; Patel D; Sammann A; Turyahabwe S; Dowdy DW; Katamba A; Cattamanchi A
PLOS Digit Health; 2023 Jun; 2(6):e0000138. PubMed ID: 37390077
[TBL] [Abstract][Full Text] [Related]
3. Explaining Differences in the Acceptability of 99DOTS, a Cell Phone-Based Strategy for Monitoring Adherence to Tuberculosis Medications: Qualitative Study of Patients and Health Care Providers.
Thomas BE; Kumar JV; Onongaya C; Bhatt SN; Galivanche A; Periyasamy M; Chiranjeevi M; Khandewale AS; Ramachandran G; Shah D; Haberer JE; Mayer KH; Subbaraman R
JMIR Mhealth Uhealth; 2020 Jul; 8(7):e16634. PubMed ID: 32735220
[TBL] [Abstract][Full Text] [Related]
4. Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda.
Cattamanchi A; Crowder R; Kityamuwesi A; Kiwanuka N; Lamunu M; Namale C; Tinka LK; Nakate AS; Ggita J; Turimumahoro P; Babirye D; Oyuku D; Berger C; Tucker A; Patel D; Sammann A; Turyahabwe S; Dowdy D; Katamba A
PLoS Med; 2021 May; 18(5):e1003628. PubMed ID: 33956802
[TBL] [Abstract][Full Text] [Related]
5. Cost and Cost-Effectiveness of a Digital Adherence Technology for Tuberculosis Treatment Support in Uganda.
Thompson RR; Kityamuwesi A; Kuan A; Oyuku D; Tucker A; Ferguson O; Kunihira Tinka L; Crowder R; Turyahabwe S; Cattamanchi A; Dowdy DW; Katamba A; Sohn H
Value Health; 2022 Jun; 25(6):924-930. PubMed ID: 35667781
[TBL] [Abstract][Full Text] [Related]
6. Stakeholders' Perceptions of Benefits of and Barriers to Using Video-Observed Treatment for Monitoring Patients With Tuberculosis in Uganda: Exploratory Qualitative Study.
Sekandi JN; Kasiita V; Onuoha NA; Zalwango S; Nakkonde D; Kaawa-Mafigiri D; Turinawe J; Kakaire R; Davis-Olwell P; Atuyambe L; Buregyeya E
JMIR Mhealth Uhealth; 2021 Oct; 9(10):e27131. PubMed ID: 34704961
[TBL] [Abstract][Full Text] [Related]
7. Digital Adherence Technologies Linked to Mobile Money Incentives for Medication Adherence Among People Living With Tuberculosis: Mixed Methods Feasibility and Acceptability Study.
Musiimenta A; Tumuhimbise W; Atukunda E; Mugaba A; Linnemayr S; Haberer J
JMIR Hum Factors; 2024 May; 11():e47996. PubMed ID: 38819905
[TBL] [Abstract][Full Text] [Related]
8. Iterative Adaptation of a Tuberculosis Digital Medication Adherence Technology to Meet User Needs: Qualitative Study of Patients and Health Care Providers Using Human-Centered Design Methods.
Patel D; Berger CA; Kityamuwesi A; Ggita J; Kunihira Tinka L; Turimumahoro P; Feler J; Chehab L; Chen AZ; Gupta N; Turyahabwe S; Katamba A; Cattamanchi A; Sammann A
JMIR Form Res; 2020 Dec; 4(12):e19270. PubMed ID: 33289494
[TBL] [Abstract][Full Text] [Related]
9. "99DOTS"techno-supervision for tuberculosis treatment - A boon or a bane? Exploring challenges in its implementation at a tertiary centre in Delhi, India.
Prabhu A; Agarwal U; Tripathy JP; Singla N; Sagili K; Thekkur P; Sarin R
Indian J Tuberc; 2020 Jan; 67(1):46-53. PubMed ID: 32192617
[TBL] [Abstract][Full Text] [Related]
10. Study protocol and implementation details for a pragmatic, stepped-wedge cluster randomised trial of a digital adherence technology to facilitate tuberculosis treatment completion.
Crowder R; Kityamuwesi A; Kiwanuka N; Lamunu M; Namale C; Tinka LK; Nakate AS; Ggita J; Turimumahoro P; Babirye D; Oyuku D; Berger CA; Tucker A; Patel D; Sammann A; Dowdy D; Stavia T; Cattamanchi A; Katamba A
BMJ Open; 2020 Nov; 10(11):e039895. PubMed ID: 33247012
[TBL] [Abstract][Full Text] [Related]
11. Patient and health system level barriers to and facilitators for tuberculosis treatment initiation in Uganda: a qualitative study.
Zawedde-Muyanja S; Manabe YC; Cattamanchi A; Castelnuovo B; Katamba A
BMC Health Serv Res; 2022 Jun; 22(1):831. PubMed ID: 35764982
[TBL] [Abstract][Full Text] [Related]
12. A pilot project: 99DOTS information communication technology-based approach for tuberculosis treatment in Rajkot district.
Thakkar D; Piparva KG; Lakkad SG
Lung India; 2019; 36(2):108-111. PubMed ID: 30829243
[TBL] [Abstract][Full Text] [Related]
13. Developing strategies to address barriers for tuberculosis case finding and retention in care among refugees in slums in Kampala, Uganda: a qualitative study using the COM-B model.
Buregyeya E; Atusingwize E; Sekandi JN; Mugambe R; Nuwematsiko R; Atuyambe L
BMC Infect Dis; 2022 Mar; 22(1):301. PubMed ID: 35346094
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and acceptability of the smart pillbox and medication label with differentiated care to support person-centered tuberculosis care among ASCENT trial participants - A multicountry study.
Tadesse AW; Mganga A; Dube TN; Alacapa J; van Kalmthout K; Letta T; Mleoh L; Garfin AMC; Maraba N; Charalambous S; Foster N; Jerene D; Fielding KL
Front Public Health; 2024; 12():1327971. PubMed ID: 38444445
[TBL] [Abstract][Full Text] [Related]
15. Impact of the 99DOTS digital adherence technology on tuberculosis treatment outcomes in North India: a pre-post study.
Chen AZ; Kumar R; Baria RK; Shridhar PK; Subbaraman R; Thies W
BMC Infect Dis; 2023 Jul; 23(1):504. PubMed ID: 37525114
[TBL] [Abstract][Full Text] [Related]
16. Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda-patient and health worker perspectives.
Semitala FC; Musinguzi A; Ssemata J; Welishe F; Nabunje J; Kadota JL; Berger CA; Katamba A; Kiwanuka N; Kamya MR; Dowdy D; Cattamanchi A; Katahoire AR
Implement Sci Commun; 2021 Jun; 2(1):71. PubMed ID: 34193311
[TBL] [Abstract][Full Text] [Related]
17. Understanding Lay Counselor Perspectives on Mobile Phone Supervision in Kenya: Qualitative Study.
Triplett NS; Johnson C; Kiche S; Dastrup K; Nguyen J; Daniels A; Mbwayo A; Amanya C; Munson S; Collins PY; Weiner BJ; Dorsey S
JMIR Form Res; 2023 Feb; 7():e38822. PubMed ID: 36729591
[TBL] [Abstract][Full Text] [Related]
18. Acceptability, Usefulness, and Ease of Use of an Enhanced Video Directly Observed Treatment System for Supporting Patients With Tuberculosis in Kampala, Uganda: Explanatory Qualitative Study.
Sekandi JN; McDonald A; Nakkonde D; Zalwango S; Kasiita V; Kaggwa P; Kakaire R; Atuyambe L; Buregyeya E
JMIR Form Res; 2023 Nov; 7():e46203. PubMed ID: 37948121
[TBL] [Abstract][Full Text] [Related]
19. Mobile Health for Tuberculosis Management in South India: Is Video-Based Directly Observed Treatment an Acceptable Alternative?
Kumar AA; De Costa A; Das A; Srinivasa GA; D'Souza G; Rodrigues R
JMIR Mhealth Uhealth; 2019 Apr; 7(4):e11687. PubMed ID: 30942696
[TBL] [Abstract][Full Text] [Related]
20. Health worker perspectives on barriers to delivery of routine tuberculosis diagnostic evaluation services in Uganda: a qualitative study to guide clinic-based interventions.
Cattamanchi A; Miller CR; Tapley A; Haguma P; Ochom E; Ackerman S; Davis JL; Katamba A; Handley MA
BMC Health Serv Res; 2015 Jan; 15():10. PubMed ID: 25609495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
